Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Huhn

Showing results (341-350 of 380) with videos related to

Pageof 38
Sort By:
Leukemia & Lymphoma|June 25, 1998
HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b/zidovudine maintenance therapyR Weiss, D Huhn, P Mitrou, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
The status of p53 in the metastatic progression of colorectal cancerI Heide, C Thiede, T Sonntag, et al.
Blood|February 15, 1997
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infectionH J Delecluse, I Anagnostopoulos, F Dallenbach, et al.
Experimental Hematology|June 1, 1996
Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteersR D Huhn, E J Yurkow, R Tushinski, et al.
The Journal of Infectious Diseases|January 6, 2018
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C VirusMichael Reid, Yifei Ma, Rebecca Scherzer, et al.
BMC Infectious Diseases|April 18, 2015
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infectionAimee C Hodowanec, Rebecca D Lee, Kirsten E Brady, et al.
Environmental Health Perspectives|May 4, 2005
Two outbreaks of occupationally acquired histoplasmosis: more than workers at riskGregory D Huhn, Connie Austin, Mark Carr, et al.
Blood|April 1, 1997
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factorM Engelhard, G Brittinger, D Huhn, et al.
Journal for Immunotherapy of Cancer|March 1, 2018
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancerWalburga Engel-Riedel, Jamie Lowe, Paulette Mattson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancerH Oettle, M Arning, U Pelzer, et al.
Pageof 38

Showing results (341-350 of 380) with videos related to

Sort By:
Pageof 38
Leukemia & Lymphoma|June 25, 1998
HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b/zidovudine maintenance therapyR Weiss, D Huhn, P Mitrou, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
The status of p53 in the metastatic progression of colorectal cancerI Heide, C Thiede, T Sonntag, et al.
Blood|February 15, 1997
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infectionH J Delecluse, I Anagnostopoulos, F Dallenbach, et al.
Experimental Hematology|June 1, 1996
Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteersR D Huhn, E J Yurkow, R Tushinski, et al.
The Journal of Infectious Diseases|January 6, 2018
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C VirusMichael Reid, Yifei Ma, Rebecca Scherzer, et al.
BMC Infectious Diseases|April 18, 2015
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infectionAimee C Hodowanec, Rebecca D Lee, Kirsten E Brady, et al.
Environmental Health Perspectives|May 4, 2005
Two outbreaks of occupationally acquired histoplasmosis: more than workers at riskGregory D Huhn, Connie Austin, Mark Carr, et al.
Blood|April 1, 1997
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factorM Engelhard, G Brittinger, D Huhn, et al.
Journal for Immunotherapy of Cancer|March 1, 2018
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancerWalburga Engel-Riedel, Jamie Lowe, Paulette Mattson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancerH Oettle, M Arning, U Pelzer, et al.
Pageof 38